Abstract: In addition to the LAM mutations (
rtS256G and
rtM267L), missense mutations in B-cell, T-cell, HLA class I and II-restricted epitopes emerged, which were to evade and escape host surveillance, leading to delayed viral clearance, persistence and disease progression.
Discussion: In fact, in addition to the immune escape mutations, two lesser-known LAM resistance mutations (
rtS256G and
rtM267L) developed (Table 1), which were previously identified in LAM-failed
CHB patients.